Disturbed coordination leading to fall with injuries was reported, particularly in elderly patients. Peripheral neuropathy (may be irreversible), polyneuropathy, hearing impairment (including deafness; reversible in most cases), and exacerbation of myasthenia gravis have also been reported during postmarketin...
Common (1% to 10%): Dizziness, somnolence Uncommon (0.1% to 1%): Hypoesthesia, neuropathy peripheral, paresthesia, tremor, vertigo, tinnitus Postmarketing reports: Extrapyramidal disorder[Ref]Gastrointestinal Common (1% to 10%): Nausea, abdominal pain Uncommon (0.1% to 1%): Constipation, dyspha...
Very common (10% or more): Paresthesia (up to 21%), taste disturbance (up to 16%), headache (up to 15%), dizziness (up to 12%), peripheral sensory neuropathy (up to 10%) Frequency not reported: Dizziness, dysgeusia, ataxia, syncope, taste loss, polyneuropathy, migraine, vertigo, tr...
Several cases of peripheral and/or optic neuropathy have been reported, mainly when the duration of therapy was longer than 28 days. For example, irreversible sensory loss and peripheral neuropathy were reported in a patient after using this drug for 6 months for actinomycosis. The time from the...
Common (1% to 10%): Headache Frequency not reported: Neuropathy, peripheral neuropathy Postmarketing reports: Somnolence, paresthesia[Ref]During 1 study, side effects of at least moderate intensity included headache; incidence was 4% with each formulation.[Ref]Musculoskeletal...
Check with your doctor right away if you are having burning, numbness, tingling, or painful sensations, weakness in the arms, hands, legs, or feet, or unsteadiness. These could be symptoms of a condition called peripheral neuropathy.
Rapid improvement in glucose control has been associated with a transitory, reversible acute painful peripheralneuropathy. However, long-term glycemic control decreases the risk.[Ref] Respiratory Very common(10% or more): Upper respiratory tract infection (up to 35%), pharyngitis (up to 17%) ...
Check with your doctor right away if you are having burning, numbness, tingling, or painful sensations in the arms, hands, legs, or feet. These could be symptoms of a condition called peripheral neuropathy. Check with your doctor right away if you are having trouble breathing or if you ...
The most common adverse reactions reported with this drug in combination with enfortumab vedotin were rash, peripheral neuropathy, fatigue, alopecia, weight loss, diarrhea, pruritus, decreased appetite, nausea, dysgeusia, urinary tract infection, constipation, and dry eye. ...
Postmarketing reports: Visual field defect, retinal vein occlusion, and retinal artery occlusion. Non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including permanent loss of vision, has been reported in temporal association with the use of this drug.[Ref]Most...